Similar Articles |
|
The Motley Fool March 28, 2005 Nathan Parmelee |
Neogen Safe for Investors? The safety-products maker reported flat earnings, but it takes the blame and plans out a rebound. Investors, take note. |
The Motley Fool March 23, 2006 Nathan Parmelee |
Neogen Still Looks Pricey The food-safety and animal-health product producer's income statement performance is impressive, but the shares are still a bit expensive. Investors, take note. |
The Motley Fool July 19, 2011 |
IDEXX Laboratories Earnings Preview Investors are on the edge of their collective seats, hoping that IDEXX Laboratories will top analyst expectations for the fifth consecutive quarter on Friday, July 22. |
The Motley Fool January 3, 2007 Rich Duprey |
Foolish Forecast: Neogen Ready to Clean Up The food- and animal-safety product manufacturer is set to report second-quarter 2007 earnings. Investors, do you want to know what Wall Street expects to see? Do you want to know what really matters? |
The Motley Fool January 3, 2012 Seth Jayson |
Neogen Increases Sales but Misses Revenue Estimate Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Neogen is outperform, with an average price target of $39.60. |
The Motley Fool February 9, 2011 Roger Friedman |
3 Winners to Watch Our chief investor has his eye on these stocks. |